Jukka Westermarck and his group received the Elias Tillandz -prize
Prof. Jukka Westermarck and his group received the Elias Tillandz -prize for the best publication of the year for his ground-breaking study on that reveals the druggability of type-2A phosphatase, which has been largely regarded as a non-druggable cancer target. Link to study.
Warmest congratulations to the whole team!
Read more:
Recent Posts
-
Christel Sourander Successfully Defends Her Thesis
Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity and Read moreSeptember 9, 2025
-
Researchers at Åbo Akademi University Discover a New Molecular Switch Regulating Breast Cancer Progression
A research group led by our our affiliated group leader Professor Lea Sistonen at Åbo Read moreSeptember 4, 2025
-
Autumn 2025 Frontiers of Science seminars start soon
Frontiers of Science is a long-running seminar series, celebrating over 25 years of bringing internationally Read moreSeptember 3, 2025
-
The Elias Tillandz Prize to Turku Bioscience Researchers
The Elias Tillandz Prize for the Best Scientific Publication of 2024 was presented for two Read moreSeptember 2, 2025
-
Registration to FFGC Sequencing day is open!
Registration to FFGC Sequencing day is open! The event is organized by Finnish Functional Genomics Read moreAugust 27, 2025
-
Dr. Inna Starskaia received a three-year training award from Breakthrough T1D
Dr. Inna Starskaia has been awarded a prestigious three-year training award from Breakthrough T1D, the Read moreAugust 22, 2025